Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Scott Daniels

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
ACS Chemical Neuroscience|November 30, 2011
Discovery, Synthesis, and Structure Activity Relationship of a Series of N-Aryl- bicyclo[2.2.1]heptane-2-carboxamides: Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel OpenerHaibo Yu, Meng Wu, Steven D Townsend, et al.
ACS Chemical Neuroscience|November 21, 2017
Medication Exposure in Highly Adherent Psychiatry PatientsJeffrey J Sutherland, Thomas M Daly, Karen Jacobs, et al.
Journal of Medicinal Chemistry|August 26, 2010
Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitorRobert R Lavieri, Sarah A Scott, Paige E Selvy, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2015
Progress towards small molecule menin-mixed lineage leukemia (MLL) interaction inhibitors with in vivo utilityTimothy Senter, Rocco D Gogliotti, Changho Han, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 26, 2018
In vitro safety pharmacology evaluation of 2-hydroxybenzylamine acetateJohn C Fuller, Lisa M Pitchford, Ryan D Morrison, et al.
Journal of Medicinal Chemistry|March 1, 2013
Development of dual PLD1/2 and PLD2 selective inhibitors from a common 1,3,8-Triazaspiro[4.5]decane Core: discovery of Ml298 and Ml299 that decrease invasive migration in U87-MG glioblastoma cellsMatthew C O'Reilly, Sarah A Scott, Kyle A Brown, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Discovery and Characterization of ML398, a Potent and Selective Antagonist of the D4 Receptor with in Vivo ActivityCynthia B Berry, Michael Bubser, Carrie K Jones, et al.
Chemmedchem|September 12, 2014
Discovery of a highly selective PLD2 inhibitor (ML395): a new probe with improved physiochemical properties and broad-spectrum antiviral activity against influenza strainsMatthew C O'Reilly, Thomas H Oguin, Sarah A Scott, et al.
ACS Chemical Neuroscience|February 24, 2017
Disease-Modifying Effects of M<sub>1</sub> Muscarinic Acetylcholine Receptor Activation in an Alzheimer's Disease Mouse ModelEvan P Lebois, Jason P Schroeder, Thomas J Esparza, et al.
The Journal of Biological Chemistry|July 29, 2014
Phospholipase D facilitates efficient entry of influenza virus, allowing escape from innate immune inhibitionThomas H Oguin, Shalini Sharma, Amanda D Stuart, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
ACS Chemical Neuroscience|November 30, 2011
Discovery, Synthesis, and Structure Activity Relationship of a Series of N-Aryl- bicyclo[2.2.1]heptane-2-carboxamides: Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel OpenerHaibo Yu, Meng Wu, Steven D Townsend, et al.
ACS Chemical Neuroscience|November 21, 2017
Medication Exposure in Highly Adherent Psychiatry PatientsJeffrey J Sutherland, Thomas M Daly, Karen Jacobs, et al.
Journal of Medicinal Chemistry|August 26, 2010
Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitorRobert R Lavieri, Sarah A Scott, Paige E Selvy, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2015
Progress towards small molecule menin-mixed lineage leukemia (MLL) interaction inhibitors with in vivo utilityTimothy Senter, Rocco D Gogliotti, Changho Han, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 26, 2018
In vitro safety pharmacology evaluation of 2-hydroxybenzylamine acetateJohn C Fuller, Lisa M Pitchford, Ryan D Morrison, et al.
Journal of Medicinal Chemistry|March 1, 2013
Development of dual PLD1/2 and PLD2 selective inhibitors from a common 1,3,8-Triazaspiro[4.5]decane Core: discovery of Ml298 and Ml299 that decrease invasive migration in U87-MG glioblastoma cellsMatthew C O'Reilly, Sarah A Scott, Kyle A Brown, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Discovery and Characterization of ML398, a Potent and Selective Antagonist of the D4 Receptor with in Vivo ActivityCynthia B Berry, Michael Bubser, Carrie K Jones, et al.
Chemmedchem|September 12, 2014
Discovery of a highly selective PLD2 inhibitor (ML395): a new probe with improved physiochemical properties and broad-spectrum antiviral activity against influenza strainsMatthew C O'Reilly, Thomas H Oguin, Sarah A Scott, et al.
ACS Chemical Neuroscience|February 24, 2017
Disease-Modifying Effects of M<sub>1</sub> Muscarinic Acetylcholine Receptor Activation in an Alzheimer's Disease Mouse ModelEvan P Lebois, Jason P Schroeder, Thomas J Esparza, et al.
The Journal of Biological Chemistry|July 29, 2014
Phospholipase D facilitates efficient entry of influenza virus, allowing escape from innate immune inhibitionThomas H Oguin, Shalini Sharma, Amanda D Stuart, et al.
Pageof 13